| Literature DB >> 28453530 |
Masakazu Sato1, Kei Kawana1,2, Katsuyuki Adachi1, Asaha Fujimoto1, Mitsuyo Yoshida1, Hiroe Nakamura1, Haruka Nishida1, Tomoko Inoue1, Ayumi Taguchi1, Juri Ogishima1, Satoko Eguchi1, Aki Yamashita1, Kensuke Tomio1, Osamu Wada-Hiraike1, Katsutoshi Oda1, Takeshi Nagamatsu1, Yutaka Osuga1, Tomoyuki Fujii1.
Abstract
While the mortality rates for cervical cancer have been drastically reduced after the introduction of the Pap smear test, it still is one of the leading causes of death in women worldwide. Additionally, studies that appropriately evaluate the risk of developing cervical lesions are needed. Therefore, we investigated whether intracellular signaling entropy, which is measured with microarray data, could be useful for predicting the risks of developing cervical lesions. We used three datasets, GSE63514 (histology), GSE27678 (cytology) and GSE75132 (cytology, a prospective study). From the data in GSE63514, the entropy rate was significantly increased with disease progression (normal < cervical intraepithelial neoplasia, CIN < cancer) (Kruskal-Wallis test, p < 0.0001). From the data in GSE27678, similar results (normal < low-grade squamous intraepithelial lesions, LSILs < high-grade squamous intraepithelial lesions, HSILs ≤ cancer) were obtained (Kruskal-Wallis test, p < 0.001). From the data in GSE75132, the entropy rate tended to be higher in the HPV-persistent groups than the HPV-negative group. The group that was destined to progress to CIN 3 or higher had a tendency to have a higher entropy rate than the HPV16-positive without progression group. In conclusion, signaling entropy was suggested to be different for different lesion statuses and could be a useful biomarker for predicting the development of cervical intraepithelial neoplasia.Entities:
Mesh:
Year: 2017 PMID: 28453530 PMCID: PMC5409150 DOI: 10.1371/journal.pone.0176353
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Measurement of the signaling entropy in GSE63514.
The entropy rate was significantly higher according to the disease progression (Kruskal-Wallis test, p < 0.0001). Cancer; invasive cancer.
Fig 2Measurement of the signaling entropy in GSE27678.
(A) Boxplot of the entropy rate from whole samples. The entropy rate increased according to the disease progression (Kruskal-Wallis test, p < 0. 001). Among them, the entropy rate from the cell line was highest, as described in the literature [9]. (B) Entropy rate from each platform. ○ represents the data obtained from the Affymetrix Human Genome U133A 2.0 Array, and * represents the data obtained from the Affymetrix Human Genome U133 Plus 2.0 Array. The distribution patterns of the entropy rate seemed slightly different among the platforms.
Fig 3Measurement of the signaling entropy in GSE75132.
The median of the entropy rate was higher in the HPV16-persistent (HPV16+) groups than the HPV-negative (HPV-) group. The group that was destined to progress to CIN3+, or the HPV16-persistent with progression group, tended to have a higher entropy rate than the HPV16-persistent without progression group.